Back to Trades
Total Value
$0
Filing Date
Jul 10, 2026
1 transaction
Trade Summary
On Jul 9, 2026, Ray Sumita, Insider, reported $0 of Cue Biopharma, Inc. (CUE) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Cue Biopharma, Inc.
- Ticker Symbol
- CUE
- CIK
- 0001645460
Insider Information
- Name
- Ray Sumita
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 9, 2026
- Accession Number
- 0001579629-26-000004
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | Common Stock | 54,589 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 9, 2026 | CUE derivative | 54,589 | — | Grant/Award | — |
Want live alerts when Ray Sumita trades again?
Download Insider Trades to track CUE, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents that grant of restricted stock units ("RSUs"). The shares subject to the RSUs vest in equal quarterly installments over a period of forty-eight (48) months, measured from the date of grant, subject to the reporting person's continued service with the issuer through each vest date.
- (F2)Represents the grant of performance stock units ("PSUs"). The PSUs are subject to certain stock-price based vesting conditions with vesting comprised of three substantially equal tranches that are eligible to vest based the achievement of a closing price per share of $33.00, $38.50 and $44.00, in each case for a period of five consecutive trading days. If the stock price targets are not satisfied by the period ending 24 months from the date of grant, the PSUs shall automatically be forfeited and cancelled without consideration.